Why this decades-old antihistamine remains a go-to treatment for anxiety and sleep
In short: First synthesized in 1956, hydroxyzine is a first-generation antihistamine that has transcended its original purpose. While it effectively blocks histamine, its unique ability to influence serotonin and dopamine receptors makes it a versatile tool for managing anxiety, nausea, and sleep, though its long-term use requires careful medical oversight.
Hydroxyzine operates primarily as a potent histamine H1 receptor inverse agonist, a mechanism that drives its sedative and antihistamine effects. Unlike many of its peers in the diphenylmethylpiperazine class, it shows a lower affinity for muscarinic acetylcholine receptors, which may reduce the risk of certain anticholinergic side effects. Beyond histamine, it acts as a weak antagonist for serotonin 5-HT2A, dopamine D2, and α1-adrenergic receptors. Researchers suggest these additional properties are likely why the drug functions as an anxiolytic, a benefit not typically seen in other antihistamines lacking this specific profile.
The drug is rapidly absorbed after oral or intramuscular administration, with effects appearing within an hour. It is metabolized in the liver, primarily into cetirizine, and exhibits a long elimination half-life—around 20 hours in adults, though this can vary significantly based on age. A PET study revealed that a 30 mg dose results in 67.6% brain H1 receptor occupancy, a level strongly associated with somnolence. While it is effective for inducing sleep, evidence suggests it is less reliable for maintaining sleep for a full eight-hour duration.
Despite its utility, hydroxyzine is not without risks. It is generally avoided in older adults due to potential severe side effects, and it is contraindicated for use alongside other central nervous system depressants. Long-term use has been linked to tardive dyskinesia, and there are concerns regarding its safety during pregnancy. Because tolerance to its sedative effects can develop within days, it is typically prescribed for short-term or as-needed use. In 2023, it ranked as the 39th most frequently written prescription in the United States, with over 15 million instances of use.
While it is a common fixture in primary care, research gaps persist. A 2022 meta-analysis found limited evidence to support its use for insomnia, and systematic reviews have noted that while it outperforms placebos for generalized anxiety, there is insufficient data to directly compare its efficacy against benzodiazepines or buspirone. As with any potent sedative, its administration requires careful supervision to avoid oversedation or complications from drug interactions.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Hydroxyzine
To cite this card, link to https://intellectplus.co.uk/app/health-hydroxyzine.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Drugs and medication · More in Health · Latest · A–Z · All topics
